Minervax
Almost half of all serious bacterial infections in newborn babies are caused by group B streptococcus (GBS). These bacteria are carried by around one in four women. Professor Gunnar Lindahl and Dr Thomas Areschoug have now developed a possible vaccine against the infection. The vaccine became basis of the pharmaceutical company Minervax. The company is now based in Denmark.Minervax website Mine
https://www.innovation.lu.se/en/minervax - 2025-04-01